{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:44:08Z","timestamp":1786128248668,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03371-8","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:21Z","timestamp":1786125681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-5417","authenticated-orcid":false,"given":"Pawe\u0142","family":"\u0141ajczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yami","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Di Cosmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha Rizwan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"El Choueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Nieto","family":"Cuervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u0141ajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellingson Silva","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"3371_CR1","doi-asserted-by":"crossref","unstructured":"D\u2019Souza S (2015) Aneurysmal Subarachnoid Hemorrhage. Journal of Neurosurgical Anesthesiology [Internet]. ;27(3):222\u201340. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4463029\/","DOI":"10.1097\/ANA.0000000000000130"},{"key":"3371_CR2","doi-asserted-by":"crossref","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Hsiang-Yi Chou S, Cruz-Flores S, Dangayach NS et al (2023) 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. ;54(7)","DOI":"10.1161\/STR.0000000000000436"},{"issue":"11","key":"3371_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1212\/WNL.0000000000003091","volume":"87","author":"M Korja","year":"2016","unstructured":"Korja M, Lehto H, Juvela S, Kaprio J (2016) Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology 87(11):1118\u20131123","journal-title":"Neurology"},{"key":"3371_CR4","unstructured":"Chauncey JM, Wieters JS (2023) Tranexamic acid [Internet]. Nih.gov. StatPearls Publishing; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532909\/"},{"key":"3371_CR5","doi-asserted-by":"crossref","unstructured":"Guo Y, Guo XM, Li RL, Zhao K, Bao QJ, Yang JC et al (2021) Tranexamic Acid for Acute Spontaneous Intracerebral Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. Front Neurol. ;12","DOI":"10.3389\/fneur.2021.761185"},{"issue":"3","key":"3371_CR6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10143-020-01324-0","volume":"44","author":"JL de Faria","year":"2020","unstructured":"de Faria JL, da Silva Brito J, Costa e Silva LT, Kilesse CTSM, de Souza NB, Pereira CU et al (2020) Tranexamic acid in Neurosurgery: a controversy indication\u2014review. Neurosurg Rev 44(3):1287\u20131298","journal-title":"Neurosurg Rev"},{"key":"3371_CR7","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.wneu.2021.12.117","volume":"160","author":"NJ Brown","year":"2022","unstructured":"Brown NJ, Wilson B, Ong V, Gendreau JL, Yi Yang C, Himstead AS et al (2022) Use of Tranexamic Acid for Elective Resection of Intracranial Neoplasms: A Systematic Review. World Neurosurg 160:e209\u2013e219","journal-title":"World Neurosurg"},{"issue":"10269","key":"3371_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","volume":"397","author":"R Post","year":"2021","unstructured":"Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW et al (2021) Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet 397(10269):112\u2013118","journal-title":"Lancet"},{"key":"3371_CR9","doi-asserted-by":"publisher","first-page":"111189","DOI":"10.1016\/j.jocn.2025.111189","volume":"135","author":"MM Al-Salihi","year":"2025","unstructured":"Al-Salihi MM, Elazim AA, Al-Jebur MS, Saha R, Siddiq F, Ayyad A et al (2025) Effect of tranexamic acid on rebleeding, mortality, and hydrocephalus in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. J Clin Neurosci 135:111189","journal-title":"J Clin Neurosci"},{"issue":"23","key":"3371_CR10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3390\/healthcare12232452","volume":"12","author":"MO Al Zayer","year":"2024","unstructured":"Al Zayer MO, Al Johani FM, Al ghamdi SA, Al Hejaili MD, Al Mukhtar FH, Al Ariany AM et al (2024) The Effectiveness and Safety of Tranexamic Acid in Treating Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Healthcare 12(23):2452","journal-title":"Healthcare"},{"key":"3371_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ajem.2021.09.051","volume":"50","author":"T Liu","year":"2021","unstructured":"Liu T, Wu L, Xue R, Ding H (2021) Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials. Am J Emerg Med 50:646\u2013653","journal-title":"Am J Emerg Med"},{"key":"3371_CR12","doi-asserted-by":"crossref","unstructured":"Ren J, Qian D, Wu J, Ni L, Qian W, Zhao G et al (2022) Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. Front Neurol. ;12","DOI":"10.3389\/fneur.2021.710495"},{"key":"3371_CR13","doi-asserted-by":"crossref","unstructured":"Hackenberger BK (2020) Bayesian meta-analysis now \u2013 let\u2019s do it. Croatian Medical Journal [Internet]. ;61(6):564\u20138. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7821360\/","DOI":"10.3325\/cmj.2020.61.564"},{"key":"3371_CR14","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds) (2019) Cochrane Handbook for Systematic Reviews of Interventions [Internet]. Wiley; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"3371_CR15","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. British Medical Journal [Internet]. ;372(71). Available from: https:\/\/www.bmj.com\/content\/372\/bmj.n71"},{"key":"3371_CR16","doi-asserted-by":"crossref","unstructured":"Gaastra B, Ren D, Alexander S, Awad IA, Blackburn S, Dor\u00e9 S et al (2022) Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices. Journal of Stroke and Cerebrovascular Diseases [Internet]. ;31(12):106845. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1052305722005390","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106845"},{"issue":"1","key":"3371_CR17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366(1):l4898","journal-title":"BMJ"},{"key":"3371_CR18","doi-asserted-by":"crossref","unstructured":"R\u00f6ver C (2020) Bayesian Random-Effects Meta-Analysis Using the bayesmeta R Package. J Stat Softw. ;93(6)","DOI":"10.18637\/jss.v093.i06"},{"key":"3371_CR19","doi-asserted-by":"publisher","unstructured":"Schwarzer G (2024) General Package for Meta-Analysis [R package meta version 8.0\u20131]. ; Available from: https:\/\/doi.org\/10.32614\/CRAN.package.meta","DOI":"10.32614\/CRAN.package.meta"},{"issue":"19","key":"3371_CR20","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/WNL.0b013e3181dd42b3","volume":"74","author":"CE Lovelock","year":"2010","unstructured":"Lovelock CE, Rinkel GJE, Rothwell PM (2010) Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology 74(19):1494\u20131501","journal-title":"Neurology"},{"issue":"6","key":"3371_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/sim.6381","volume":"34","author":"RM Turner","year":"2014","unstructured":"Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JPT (2014) Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med 34(6):984\u2013998","journal-title":"Stat Med"},{"key":"3371_CR22","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ [Internet]. ;336(7650):924\u20136. Available from: https:\/\/www.bmj.com\/content\/336\/7650\/924","DOI":"10.1136\/bmj.39489.470347.AD"},{"issue":"5","key":"3371_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","volume":"10","author":"M Kaste","year":"1979","unstructured":"Kaste M, Ramsay M (1979) Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke 10(5):519\u2013522","journal-title":"Stroke"},{"issue":"1\u20132","key":"3371_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01402177","volume":"102","author":"SA Tsementzis","year":"1990","unstructured":"Tsementzis SA, Hitchcock ER, Meyer A (1990) Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. Acta Neurochir 102(1\u20132):1\u201310","journal-title":"Acta Neurochir"},{"issue":"1","key":"3371_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jcp.33.Suppl_14.68","volume":"s3\u201314","author":"H Fodstad","year":"1980","unstructured":"Fodstad H (1980) Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage. J Clin Pathol s3\u201314(1):68\u201373","journal-title":"J Clin Pathol"},{"issue":"7","key":"3371_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM198408163110703","volume":"311","author":"M Vermeulen","year":"1984","unstructured":"Vermeulen M, Lindsay KW, Murray GD, Koon Cheah F, Hijdra A, Muizelaar JP et al (1984) Antifibrinolytic Treatment in Subarachnoid Hemorrhage. N Engl J Med 311(7):432\u2013437","journal-title":"N Engl J Med"},{"issue":"4","key":"3371_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","volume":"97","author":"J Hillman","year":"2002","unstructured":"Hillman J, Fridriksson S, Nilsson O, Yu Z, S\u00e4veland H, Jakobsson KE (2002) Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97(4):771\u2013778","journal-title":"J Neurosurg"},{"issue":"4","key":"3371_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","volume":"33","author":"W Hu","year":"2019","unstructured":"Hu W, Xin Y, Chen X, Song Z, He Z, Zhao Y (2019) Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review. CNS Drugs 33(4):327\u2013336","journal-title":"CNS Drugs"},{"key":"3371_CR29","doi-asserted-by":"crossref","unstructured":"Calviere L, Gathier CS, Rafiq M, Koopman I, Rousseau V, Raposo N et al (2022) Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies. Front Neurol. ;13","DOI":"10.3389\/fneur.2022.836268"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03371-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:29Z","timestamp":1786125689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03371-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":29,"alternative-id":["3371"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03371-8","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required due to review nature of study.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":4,"name":"Ethics","label":"<b>Ethical Approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Gemini Pro to improve readability of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":5,"name":"Ethics","label":"Generative AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Trial Registry Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}